HR 318 United States House · 117th Congress

Safe Testing at Residence Telehealth Act of 2021

Summary

Safe Testing at Residence Telehealth Act of 2021 This bill provides for Medicare payment of certain at-home diagnostic tests and telehealth assessments that are provided in relation to COVID-19 (i.e., coronavirus disease 2019). Specifically, during the public health emergency, the bill requires Medicare payment of diagnostic tests for respiratory conditions other than COVID-19 (e.g., influenza) that are used to finalize a COVID-19 diagnosis and of COVID-19 blood tests that are ordered via telehealth, as well as for related telehealth assessments, regardless of whether the practitioner who orders the test is the one who furnishes it and regardless of the location of the practitioner. The bill requires practitioners to report specified demographic data with respect to such tests and services in order to receive payment, and prohibits payment for in-person tests that were already ordered via telehealth.

Bill status in committee 1 of 4 stages cleared

Introduction

Jan 2021

Committee Review

Floor Vote

President

Introduced Jan 13, 2021 Last action Jan 14, 2021

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Jan 14, 2021

Committee

Referred to the Subcommittee on Health.

lower

Jan 13, 2021

Committee

Referred to the Subcommittee on Health.

lower

Jan 13, 2021

Committee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

lower

Jan 13, 2021

Introduced

Introduced in House

lower

1 primary · 4 co-sponsors